Patent · US Active

Construction and application of differentially regulated tissue-engineered nerve grafts

US11110202B1 · kind B1 · utility

1Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 2019
Grant dateSep 7, 2021
Priority date
Expiry dateSep 11, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/32
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A differential tissue-engineered nerve including motor-like nerves and sensory-like nerves. The motor-like nerve and the sensory-like nerve respectively includes a motor-like nerve outer tube and a motor-like nerve fiber in the outer tube as well as a sensory-like nerve outer tube and a sensory-like nerve fiber in the outer tube. Schwann cells and/or fibroblasts derived from motor nerves and sensory nerves are respectively contained in surfaces or pores of the motor-like and sensory-like nerve outer tubes. Transsynaptic signal molecules Neuroligin-1 and Neuroligin-2 are contained in surfaces or pores of the motor-like and sensory-like nerve fibers. Neuroligin-1 is selectively used to specifically promote synaptic remodeling of motor neurons, while Neuroligin-2 is selectively used to specifically promote synaptic remodeling of sensory neurons, so that repair efficiency of motor nerve cells and sensory nerve cells is improved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.